| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 11.008.058 $ | 98,95 | 116.223 | |||||||
| Eli Lilly & Co. | Eli Lilly & Co. | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 757.961 $ | 6,81 | 811 | |
| AbbVie, Inc. | AbbVie, Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 732.012 $ | 6,58 | 3.464 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 689.780 $ | 6,20 | 3.001 | |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 648.710 $ | 5,83 | 1.751 | |
| AstraZeneca plc | AstraZeneca plc | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 507.887 $ | 4,57 | 2.677 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 468.273 $ | 4,21 | 4.289 | |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 389.412 $ | 3,50 | 6.427 | |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 354.430 $ | 3,19 | 740 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 329.022 $ | 2,96 | 719 | |
| CVS Health Corp. | CVS Health Corp. | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 301.343 $ | 2,71 | 3.618 | |
| Novo Nordisk A/S | Novo Nordisk A/S, Class B | EC | DK0062498333 | Long | Modellwert (Stufe 2) | 295.327 $ | 2,65 | 6.943 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 294.623 $ | 2,65 | 723 | |
| Hoya Corp. | Hoya Corp. | EC | JP3837800006 | Long | Modellwert (Stufe 2) | 261.441 $ | 2,35 | 1.400 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 243.229 $ | 2,19 | 344 | |
| Boston Scientific Corp. | Boston Scientific Corp. | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 227.329 $ | 2,04 | 3.946 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 218.650 $ | 1,97 | 803 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 217.964 $ | 1,96 | 510 | |
| Danaher Corp. | Danaher Corp. | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 211.877 $ | 1,90 | 1.184 | |
| Edwards Lifesciences Corp. | Edwards Lifesciences Corp. | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 203.323 $ | 1,83 | 2.435 | |
| McKesson Corp. | McKesson Corp. | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 198.094 $ | 1,78 | 243 | |
| Stryker Corp. | Stryker Corp. | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 177.103 $ | 1,59 | 562 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 261.932 $ | 2,35 | 334 | |
| Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Ltd. | EC | IL0006290147 | Long | Modellwert (Stufe 2) | 156.986 $ | 1,41 | 4.466 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 153.532 $ | 1,38 | 796 | |
| Centene Corp. | Centene Corp. | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 147.057 $ | 1,32 | 2.739 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 144.610 $ | 1,30 | 764 | |
| Zoetis, Inc. | Zoetis, Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 130.606 $ | 1,17 | 1.136 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 129.125 $ | 1,16 | 226 | |
| Lonza Group AG | Lonza Group AG (Registered) | EC | CH0013841017 | Long | Modellwert (Stufe 2) | 122.964 $ | 1,11 | 200 | |
| Novartis AG | Novartis AG (Registered) | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 115.719 $ | 1,04 | 783 | |
| Fresenius SE & Co. KGaA | Fresenius SE & Co. KGaA | EC | DE0005785604 | Long | Modellwert (Stufe 2) | 115.408 $ | 1,04 | 2.383 | |
| IQVIA Holdings, Inc. | IQVIA Holdings, Inc. | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 114.977 $ | 1,03 | 726 | |
| Sartorius AG | Sartorius AG (Preference) | EC | DE0007165631 | Long | Modellwert (Stufe 2) | 101.680 $ | 0,91 | 398 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 98.795 $ | 0,89 | 1.327 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 95.489 $ | 0,86 | 1.152 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 93.973 $ | 0,84 | 1.257 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 87.029 $ | 0,78 | 1.304 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 78.677 $ | 0,71 | 343 | |
| Align Technology, Inc. | Align Technology, Inc. | EC | 016255101 | Long | Börsenkurs (Stufe 1) | 76.916 $ | 0,69 | 437 | |
| Immunome, Inc. | Immunome, Inc. | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 76.872 $ | 0,69 | 3.351 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 74.868 $ | 0,67 | 4.266 | |
| Dexcom, Inc. | Dexcom, Inc. | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 71.222 $ | 0,64 | 1.196 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 70.180 $ | 0,63 | 533 | |
| Genmab A/S | Genmab A/S | EC | DK0010272202 | Long | Modellwert (Stufe 2) | 84.036 $ | 0,76 | 788 | |
| Daiichi Sankyo Co. Ltd. | Daiichi Sankyo Co. Ltd. | EC | JP3475350009 | Long | Modellwert (Stufe 2) | 68.225 $ | 0,61 | 4.200 | |
| Convatec Group plc | Convatec Group plc | EC | GB00BD3VFW73 | Long | Modellwert (Stufe 2) | beschränkt | 67.339 $ | 0,61 | 23.481 |
| Cigna Group (The) | Cigna Group (The) | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 67.124 $ | 0,60 | 231 | |
| Medtronic plc | Medtronic plc | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 65.424 $ | 0,59 | 808 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 60.392 $ | 0,54 | 2.446 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 58.564 $ | 0,53 | 584 | |
| Bio-Techne Corp. | Bio-Techne Corp. | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 46.635 $ | 0,42 | 843 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 46.479 $ | 0,42 | 1.201 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 41.944 $ | 0,38 | 636 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 34.663 $ | 0,31 | 112 | |
| Viridian Therapeutics, Inc. | Viridian Therapeutics, Inc. | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 31.314 $ | 0,28 | 2.323 | |
| Evommune, Inc. | Evommune, Inc. | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 29.988 $ | 0,27 | 1.260 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 29.981 $ | 0,27 | 535 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 29.543 $ | 0,27 | 68 | |
| 11.008.058 $ | 98,95 | 116.223 |